🇺🇸 FDA
Patent

US 8921335

Oral delivery of nucleic acid-based gene interfering agents by Salmonella

granted A61KA61K35/74A61K48/00

Quick answer

US patent 8921335 (Oral delivery of nucleic acid-based gene interfering agents by Salmonella) held by The Regents of the University of California expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K35/74, A61K48/00